Oxford, NY, United States of America

Margaret A McGowan

This inventor holds 1 USPTO granted patent. Top assignee: Norwich Eaton Pharmaceuticals, Inc.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Margaret A McGowan. Retrieved from https://idiyas.com/inventor/margaret-a-mcgowan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Margaret A. McGowan

Introduction

Margaret A. McGowan, an accomplished inventor based in Oxford, NY, has made significant contributions to the field of pharmaceuticals. With a focus on compositions for the administration of nitrofurantoin, her inventions have implications for both human and animal health.

Latest Patents

Margaret holds a notable patent for "Liquid suspensions of nitrofurantoin." This patent details compositions designed for the effective administration of nitrofurantoin, a key antibiotic used to treat various infections. This innovation reflects her commitment to enhancing therapeutic options and improving patient outcomes.

Career Highlights

Margaret has been associated with Norwich Eaton Pharmaceuticals, Inc., a company known for its dedication to pharmaceutical advancements. Her work there emphasizes her role as a leader in innovation, showcasing her ability to blend scientific knowledge with practical applications.

Collaborations

Throughout her career, Margaret has collaborated with esteemed colleagues such as Vijay Shahi and Michael J. Kane. These partnerships underscore the importance of teamwork in driving innovation and achieving successful outcomes in the field of pharmaceutical research.

Conclusion

In summary, Margaret A. McGowan stands out as an influential inventor in the pharmaceutical industry. Her patent for liquid suspensions of nitrofurantoin showcases her ingenuity and dedication to improving health solutions. With supportive collaborations and a commitment to her field, Margaret continues to inspire future innovations within the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…